Articles tagged with: Stem Cell Transplant
Significant improvements in donor stem cell transplantation have been made in recent years. As a result, donor transplantation – a procedure during which a patient receives stem cells from a healthy donor – has become safer and typically more successful for patients.
The majority of patients undergoing donor stem cell transplantation receive stem cells from unrelated donors. In these cases, a close match between donor and recipient tissue types is known to play an important important role in transplant outcomes.
A group of German researchers last fall published results of …
A group of Spanish researchers published a summary last year of the patterns of relapse and progression they observed in multiple myeloma patients who underwent stem cell transplantation as part of their upfront therapy.
The researchers observed relapse in over half of the patients included in the study. Among these patients, the majority had only achieved a partial response after transplantation.
They also found that how a patient relapsed had an impact on their prognosis after relapse. Patients who relapsed based solely on changes in disease markers, such as their …
Results of several studies investigating Revlimid maintenance therapy for multiple myeloma will be presented at this year’s American Society of Hematology (ASH) annual meeting, which starts later this week.
Today’s article previews the results of the key Revlimid maintenance studies that will be presented at the meeting, drawing on findings published in the meeting abstracts. Some of the study results, it should be noted, will be updated during the presentations at ASH this week and early next week.
The results to be presented at ASH are unlikely to settle the …
As The Beacon continues its ‘ASH Preview’ series about myeloma research that will be presented at the American Society of Hematology (ASH) meeting in early December, this article focuses on novel immunotherapy approaches that are being studied in clinical trials.
Abstracts for the ASH presentations are now available, although many contain preliminary information that will be updated at the meeting.
The Beacon’s ASH preview articles are intended to highlight the meeting’s most interesting myeloma-related studies.
The first several of the preview articles, which were published over …
Findings from a recent retrospective study conducted at the Mayo Clinic indicate that autologous stem cell transplantation is an effective treatment option for multiple myeloma patients with advanced kidney disease.
The majority of patients (87 percent) responded to the treatment, with 40 percent achieving a complete response. According to the researchers, this complete response rate is similar to those seen in other studies of stem cell transplantation for myeloma patients with kidney disease.
However, the researchers found little evidence that transplantation significantly improves kidney function in patients with advanced kidney …